Hyloris Pharmaceuticals

Hyloris is a Liège-based specialty pharma scale-up with an extensive pipeline of redeveloped drugs (including intravenous aspirin for acute coronary syndrome). Listed on Euronext Brussels, and in 2023 raised significant capital for further development.